About Adynxx Inc.
Adynxx develops brivoligide (AYX1) and AYX2, antisense oligonucleotides designed to prevent the transition from acute to chronic pain by targeting EGR1 gene expression.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to Adynxx Inc.. Response typically within 48 hours.